Results 91 to 100 of about 70,554 (240)

Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin

Patient Related Outcome Measures, 2011
Bob Djavan, Seyed Saeid Dianat, Amir KazzaziNew York University, Department of Urology, New York, USABackground: Benign prostatic hyperplasia, the fourth most commonly diagnosed medical condition in the elderly, is a major underlying cause of lower ...
Djavan B, Dianat SS, Kazzazi A
doaj  

Pterostilbene Effect on Inflammatory and Oxidation Markers in Benign Prostatic Hyperplasia Rats Model

Iraqi Journal of Pharmaceutical Sciences
Pterostilbene is a potent anti-inflammatory and antioxidant used to treat benign prostatic hyperplasia, which is brought on by the induction of testosterone propionate.
Mohammed Ridha Jawad, Ghaith Ali Jasim
doaj   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Prostate blood flow in patients with benign prostatic hyperplasia complicated by urine retention

RUDN Journal of Medicine, 2012
Benign prostatic hyperplasia is the most frequent disease among middle and old aged men and connected with increasing of lifetime of men. The incidence of the disease is 42% to 87% in different aged groups.
E A Atamanova, V P Avdoshin, M I Andryukhin, V V Chugaev   +3 more
doaj  

Assessing the Influence of Sexual Activity on Benign Prostatic Hyperplasia [PDF]

International Journal of Medical Arts
Background: Benign prostatic hyperplasia [BPH] is a frequent cause of lower urinary tract symptoms [LUTS] in men and is a common histological finding, particularly in aging men.
Muhammed Elgendy, Ahmed Salem, Ahmad Abdel-Hameed, Amr Hussein   +3 more
doaj   +1 more source

Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway

Surgical Practice, EarlyView.
Abstract Objective Medical devices are reviewed by the US Food and Drug Administration (FDA) for safety and effectiveness. Class II devices can receive 510(k) clearance if they are “substantially equivalent” to an existing predicate device. This process can be repeated iteratively, leading to a lineage of predicates for newly cleared devices.
Yiting Lin, Amir Khan, Arvin George, Mohummad Minhaj Siddiqui   +3 more
wiley   +1 more source

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients [PDF]

, 2018
Background. Chronic kidney disease (CKD) is a highly prevalent condition. Urologic disorders are known causes of CKD, but often remain undiagnosed and underestimated also for their insidious onset and slow progression.
Ciccariello, Mauro, Esposito, Ylenia, Galani, Alessandro, Lai, Silvia, Mangiulli, MARCO GIOVANNI, Mastroluca, Daniela, Pastore, Serena, Pierella, Federico, Piloni, Leonardo, Pintus, Giovanni, Salciccia, Stefano, Shahabadi, Hossein, VON HELAND, Magnus   +12 more
core  

Use of parallel fluorescent confocal microscopy for detection of prostatic adenocarcinoma

BJU International, EarlyView.
Objective To provide a histological catalogue and defined criteria for the diagnosis of prostatic adenocarcinoma and its variants using the fluorescent confocal microscope (FCM) platform. Methods A total of 22 radical prostatectomy specimens were serially sectioned and scanned with the FCM.
Kevin Clare, Kenneth Haines, Jeremy Littlefield, Asher Mandel, Hannah Sur, Neeraja Tillu, Henry Jodka, Daniel Ajabshir, Fatima Ahmad, Chahat Arora, Cristina Pasat‐Karasik, Monali Fatterpekar, Ash Tewari, Ming Zhou   +13 more
wiley   +1 more source

Rescoring the NIH chronic prostatitis symptom index: nothing new. [PDF]

, 2009
The National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI) is a commonly used 13-item questionnaire for the assessment of symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Calhoun, EA, Clemens, JQ, Crowley, EM, Dunn, RL, Landis, JR, Litwin, MS, McNaughton-Collins, M   +6 more
core  

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, Sanika Mohagaonkar, Matti Walsdorff, Tanja Zeller, Filip Berisha, Viacheslav O. Nikolaev, Sergei D. Rybalkin   +8 more
wiley   +1 more source